Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (21-30 of 336) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|November 21, 2008
Prognosis of mantle cell lymphoma: is it all about proliferation?Oliver Weigert, Martin Dreyling
Deutsche Medizinische Wochenschrift (1946)|November 1, 2022
[Aggressive lymphoma (DLBCL, MCL) - what's new?]Elisabeth Silkenstedt, Martin Dreyling
Haematologica|June 29, 2017
Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?Simone Ferrero, Martin Dreyling,
Current Treatment Options in Oncology|April 30, 2003
Mantle cell lymphoma: therapeutic strategies are different from CLLWolfgang Hiddemann, Martin Dreyling
Current Hematologic Malignancy Reports|September 13, 2011
Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?Roswitha Forstpointner, Martin Dreyling
Deutsche Medizinische Wochenschrift (1946)|January 10, 2018
[Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma]Christian Buske, Martin Dreyling
Leukemia & Lymphoma|April 16, 2023
Follicular lymphoma: an update on biology and optimal therapyLuca Fischer, Martin Dreyling
Hemasphere|April 26, 2021
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular LymphomaMarco Ladetto, Martin Dreyling
Blood|July 26, 2024
Treatment of relapsed/refractory MCLElisabeth Silkenstedt, Martin Dreyling
Hemasphere|September 5, 2020
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell LymphomaKim Linton, Martin Dreyling
Pageof 34

Showing results (21-30 of 336) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|November 21, 2008
Prognosis of mantle cell lymphoma: is it all about proliferation?Oliver Weigert, Martin Dreyling
Deutsche Medizinische Wochenschrift (1946)|November 1, 2022
[Aggressive lymphoma (DLBCL, MCL) - what's new?]Elisabeth Silkenstedt, Martin Dreyling
Haematologica|June 29, 2017
Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?Simone Ferrero, Martin Dreyling,
Current Treatment Options in Oncology|April 30, 2003
Mantle cell lymphoma: therapeutic strategies are different from CLLWolfgang Hiddemann, Martin Dreyling
Current Hematologic Malignancy Reports|September 13, 2011
Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom?Roswitha Forstpointner, Martin Dreyling
Deutsche Medizinische Wochenschrift (1946)|January 10, 2018
[Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma]Christian Buske, Martin Dreyling
Leukemia & Lymphoma|April 16, 2023
Follicular lymphoma: an update on biology and optimal therapyLuca Fischer, Martin Dreyling
Hemasphere|April 26, 2021
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular LymphomaMarco Ladetto, Martin Dreyling
Blood|July 26, 2024
Treatment of relapsed/refractory MCLElisabeth Silkenstedt, Martin Dreyling
Hemasphere|September 5, 2020
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell LymphomaKim Linton, Martin Dreyling
Pageof 34